iShares Genomics Immunology and Healthcare ETF (IDNA)
iShares Genomics Immunology and Healthcare ETF operates in the Asset Management industry of the Financial Services sector, headquartered in San Francisco, CA, US. The stock last traded at $35.42, up 0.63% on the session, giving a market capitalisation of $166.1M. Its beta of 1.11 implies it has historically moved more than the broad market.
The iShares Genomics Immunology and Healthcare ETF (IDNA) is designed to mirror the investment performance of a specific index. This index comprises companies operating in both mature and emerging global markets. These businesses are strategically chosen for their potential to capitalize on sustained innovation and expansion within the crucial fields of genomics, immunology, and bioengineering.
iShares Genomics Immunology and Healthcare ETF is most often compared with the following Financial Services names: